List of works - Jee-Fu Huang

A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels

scientific article published in December 2006

A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration

scientific article published on April 2009

A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan

scientific article published in May 1999

A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors

scientific article published on July 2004

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan

scientific article published on 18 November 2016

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy

scientific article

Abnormal Liver Function Test Predicts Type 2 Diabetes: a Community-Based Prospective Study: Response to Cho et al

article

Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.

scientific article published on 15 September 2009

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B

scientific article published on 16 March 2007

Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy

scientific article

Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.

scientific article published in June 2007

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

scientific article published on 20 January 2012

Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.

scientific article published on 9 September 2008

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study

scientific article published on 22 April 2008

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

scientific article

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

scientific article published on 7 February 2009

CT evaluation of gastrointestinal tract perforation

scientific article published in September 2004

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan

scientific article published on 7 July 2008

Cirrhosis as a Risk Factor for Tuberculosis Infection—A Nationwide Longitudinal Study in Taiwan

scientific article published on 14 May 2014

Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan).

scientific article published in November 2002

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution

scientific article published on 18 December 2014

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan ⬇️

scientific article published on August 9, 2010

Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients

scientific article published in August 2009

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

scientific article published on 24 June 2013

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients

scientific article

Diagnosis of Icteric-Type Hepatocellular Carcinoma by Fine Needle Aspiration

scientific article published on 01 September 2006

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

scientific article published on 28 August 2019

Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C

scientific article published on 13 November 2019

Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors

scientific article published in December 2006

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation

scientific article published on 26 September 2007

Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease

scientific article published on 01 July 2020

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

scientific article published on 01 June 2020

Exosome-derived differentiation antagonizing non-protein coding RNA with risk of HCV-related hepatocellular carcinoma recurrence

scientific article published on 21 December 2020

Glucose abnormalities in hepatitis C virus infection.

scientific article published on 29 December 2012

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

scientific article published in July 2010

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

scientific article published on 28 November 2019

Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.

scientific article published in February 2009

Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.

scientific article

Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication

scientific article published on 01 June 2007

Hepatitis C virus infection among children in aboriginal areas in Taiwan.

scientific article

Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection

scientific article (publication date: 2014)

Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan

scientific article

High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al.

scientific article published in September 2008

Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients

scientific article

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients

scientific article

Imaging of transmural migration of a retained surgical sponge: a case report

scientific article published in November 2004

Incidence and clinical outcome of icteric type hepatocellular carcinoma

scientific article published on 01 February 2002

Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients

scientific article published on 6 February 2009

Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection

scientific article published in March 2010

Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier

scientific article published on 01 April 2011

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.

scientific article

Letter to the Editors: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

scientific article published on 22 January 2020

Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients

scientific article published in January 2011

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

scientific article

Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease

article

Outcome assessment in acute pancreatitis patients

scientific article published on 12 January 2013

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

scientific article published on 3 July 2015

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues

scientific article published in May 2008

Pegylated interferon plus ribavirin therapy improves pancreatic β‐cell function in chronic hepatitis C patients ⬇️

scientific article published on May 17, 2011

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients

scientific article

Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups

scientific article published on 20 April 2011

Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections

scientific article published on January 2008

Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.

scientific article published in January 2009

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

scientific article

Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2.

scientific article published on July 2008

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns

scientific article published on June 2009

Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues

scientific article published in October 2007

Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?

scientific article

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.

scientific article published on June 2008

Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure

scientific article published on August 2008

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure

scientific article published on September 2008

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment

scientific article published on 05 November 2020

Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection

scientific article published on 12 July 2008

Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities

scientific article published on 03 June 2020

Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.

scientific article published in February 2008

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin

scientific article

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir

scientific article published on 15 August 2019

Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver

scientific article

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

scientific article published in January 2011

SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan

scientific article published in January 2006

Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy

scientific article published on 04 April 2020

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan

scientific article published in May 2007

Tarry Stool in a Man With Acute Pancreatitis

scientific article published on 21 June 2012

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population

scientific article published on 5 April 2011

The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities

scientific article

The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies

scientific article published on May 2007

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy

scientific article published in June 2006

The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.

scientific article

Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment

scientific article published on 12 October 2016

Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?

scientific article published in September 2006

Viral hepatitis infections in southern Taiwan: a multicenter community-based study

scientific article published on September 2010

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients ⬇️

scientific article published on March 19, 2013

List of works by Jee-Fu Huang

A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels

A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration

A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan

A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy

Abnormal Liver Function Test Predicts Type 2 Diabetes: a Community-Based Prospective Study: Response to Cho et al

Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B

Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy

Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients

Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

CT evaluation of gastrointestinal tract perforation

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan

Cirrhosis as a Risk Factor for Tuberculosis Infection—A Nationwide Longitudinal Study in Taiwan

Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan).

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan ⬇️

Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients

Diagnosis of Icteric-Type Hepatocellular Carcinoma by Fine Needle Aspiration

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C

Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation

Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

Exosome-derived differentiation antagonizing non-protein coding RNA with risk of HCV-related hepatocellular carcinoma recurrence

Glucose abnormalities in hepatitis C virus infection.

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.

Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.

Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication

Hepatitis C virus infection among children in aboriginal areas in Taiwan.

Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection

Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan

High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al.

Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients

Imaging of transmural migration of a retained surgical sponge: a case report

Incidence and clinical outcome of icteric type hepatocellular carcinoma

Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients

Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection

Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.

Letter to the Editors: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

Linkage of the hepatitis C virus genotype and interleukin-28B genetic polymorphisms in Asian patients

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease

Outcome assessment in acute pancreatitis patients

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues

Pegylated interferon plus ribavirin therapy improves pancreatic β‐cell function in chronic hepatitis C patients ⬇️

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients

Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups

Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections

Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2.

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns

Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues

Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.

Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment

Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection

Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities

Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir

Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients